C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/4365 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2346084
The present invention concerns the compounds of formula (I), the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein each R1 is independently hydrogen, halogen, C1-6 alkyl, nitro, hydroxy or C1-4 alkyloxy; Alk is C1-6 alkanediyl; n is 1 or 2; p is 0, 1 or 2; D is an optionally substituted mono-, bi- or tricyclic nitrogen containing heterocycle having central .alpha.2-adrenoceptor antagonist activity. It further relates to their preparation, compositions comprising them and their use as a medicine.
La présente invention concerne des composés représentés par la formule générale (I), certains de leurs N-oxides, certains de leurs sels d'addition pharmaceutiquement admis, et leurs formes stéréochimiquement isomères. En l'occurrence, chaque R<1> est indépendamment hydrogène, halogène, C1-C6 alkyle, nitro, hydroxy ou C1-C4 alkyloxy. Alk est C1-C6 alkanediyle. "n" vaut 1 ou 2. "p" vaut 0, 1 ou 2. Enfin, D est un azote monocyclique, bicyclique ou tricyclique éventuellement substitué contenant un hétérocycle présentant une activité centrale antagoniste de l' alpha 2-adrénocepteur. L'invention concerne en outre la préparation de ces composés, des compositions les contenant et leur utilisation comme médicament.
Bischoff Francois Paul
Kennis Ludo Edmond Josephine
Pieters Serge Maria Aloysius
Gowling Lafleur Henderson Llp
Janssen Pharmaceutica N.v.
LandOfFree
Benzothieno[3,2-c]pyridines as .alpha.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothieno[3,2-c]pyridines as .alpha.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothieno[3,2-c]pyridines as .alpha.2 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1827052